- Bay Area Times
- Posts
- iRobot files for bankruptcy after restructuring deal with Chinese supplier
iRobot files for bankruptcy after restructuring deal with Chinese supplier

Top stories today:
- iRobot files for bankruptcy after restructuring deal
- OpenAI said to scrap 6-month equity vesting cliff for new hires
- OpenEvidence said to raise $250M at $12B post-money valuation
- SpaceX insider sale said to peg valuation at $800B ahead of 2026 IPO
- Mira Murati’s Thinking Machines Lab launches Tinker API
- Elon’s X said to post Q3 revenue +17% YoY to $752M, EBITDA +16%
0. Data and calendar

All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).

All times are ET.
Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):
1. iRobot files for bankruptcy after restructuring deal with Chinese supplier

China’s Shenzhen PICEA Robotics and its subsidiary will take over the robot maker.
iRobot’s common stock will be wiped out under the proposed Chapter 11 plan.
iRobot will continue operating as a going concern, according to the filing.
2022: Amazon offered $1.4B to acquire iRobot, but the deal collapsed after regulatory pushback in the EU.
2. OpenAI said to scrap 6-month equity vesting cliff for new hires

Representational image generated using ChatGPT.
Last week: OpenAI reportedly informed staff of the change.
The move could help retain new hires, removing the requirement that employees work at least six months before equity begins vesting.
Apr.: OpenAI previously shortened its vesting cliff from 12 months to six months.
Elon Musk’s xAI made a similar change in late summer.
Tomorrow.bio is leading human cryopreservation across Europe and the US.
Cryopreservation involves placing a human into a complete biological pause after their legal death, to preserve them until medical technology advances enough to treat their cause of death and revive them.
You can now use the code BAY10 for 10% off your membership. Ready to bet on the future?
*Bay Area Times partner.
4. OpenEvidence said to raise $250M at $12B post-money valuation


